Authors' reply

Am J Pathol. 2014 Apr;184(4):1251-2. doi: 10.1016/j.ajpath.2014.02.001.

Authors

Serena Zacchigna¹, Matteo Biasotto², Francesco Zanatta³

Affiliations

¹ International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
² Dental Sciences University and Hospital of Trieste, Trieste, Italy.
³ Eltech s.r.l., Treviso, Italy.

PMID: 24655381
DOI: 10.1016/j.ajpath.2014.02.001

Abstract

This Correspondence is a Reply to Significant Errors and Misdirection in Class IV Laser Therapy Study by Carroll.

Copyright © 2014 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Publication types

Letter
Comment

MeSH terms

Animals
Antineoplastic Agents / adverse effects*
Female
Humans
Laser Therapy*
Male
Neoplasms / drug therapy*
Stomatitis*

Substances

Antineoplastic Agents